Funding Opportunities

Funding new arms of multi-arm trials for rare cancers

Thread Post   Created on Fri, December 20, 2019 7:09 AM
Gauthier Bouche
ACF Belgium - The Anticancer Fund (Partner)

We, the Anticancer Fund, a Belgian non-profit organization with an international scope, have joined forces with the Rising Tide Foundation for Clinical Cancer Research (RTFCCR), a Swiss-based non-profit organization, for a unique opportunity to support high quality clinical trials focusing on drug repurposing and therapy optimization, with special interest in the following areas:

  • Rare cancers (<6/100,000)
  • ‘Financial orphan’ drugs (commercially neglected drugs)
  • Off patent drugs
  • Prognostic and/or predictive biomarkers

We call upon all investigators to submit proposals, where funding is required to initiate a new arm of an existing multi-arm trial. Requirements include having a strong rationale with rigorous and compelling supportive data, in addition to a detailed statistical design and methodology.

Amount available for this call for proposals will be at least US$ 3 million. The amount allocated per grant will depend on the number of proposals selected for funding. Application Deadline is February 28, 2020

All information can be found here:

Please share this information with anyone potentially interested and/or retweet to spread the news:

Replies: 0